Prevalence and incidence of diabetes in HIV-infected minority patients on protease inhibitors.

@article{Salehian2005PrevalenceAI,
  title={Prevalence and incidence of diabetes in HIV-infected minority patients on protease inhibitors.},
  author={Behrouz Salehian and Josephine Bilas and Mohsen Bazargan and Mohammad Amir Abbasian},
  journal={Journal of the National Medical Association},
  year={2005},
  volume={97 8},
  pages={1088-92}
}
In HIV-infected patients, the use of protease inhibitors (PIs) is associated with a constellation of abdominal obesity; buffalo hump; decreased facial and subcutaneous fat; hyperlipidemia and type-2 diabetes mellitus, a so-called HAART-associated dysmetabolic syndrome. The incidence and prevalence of one of its components, the type-2 diabetes mellitus, among minority population is unknown. In August and September 1999, we reviewed 101 charts of HIV-infected patients who visited an inner-city… CONTINUE READING
Highly Cited
This paper has 30 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Human Immunodeficiency Virus and Risk of Type 2 Diabetes in a Large Adult Cohort in Jos, Nigeria

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • 2016
View 4 Excerpts
Highly Influenced

Factors associated with diabetes mellitus among adults with tuberculosis in a large European city, 2000-2013.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease • 2015

Similar Papers

Loading similar papers…